4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-045235
Chief Executive Officer bought 80,000 shares at $1.24 ($99,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thye Dirk Chief Executive Officer | 2023-08-08 | Purchase | +80,000 | $1.24 | $99,200 | 360,911 | D |
| Open-market purchases · 80,000 sh · avg $1.24 · $99,200 | |||||||
Loading xslF345X05/doc4.xml…